Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mercer

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 10, 2020
Correlating serum alpha-fetoprotein in hepatocellular carcinoma with response to Yttrium-90 transarterial radioembolization with glass microspheres (TheraSphere™)Neal Bhutiani, Stephen J O'Brien, Erin E Priddy, et al.
Molecular Pharmacology|February 12, 2005
Investigations of calsequestrin as a target for anthracyclines: comparison of functional effects of daunorubicin, daunorubicinol, and trifluoperazineHenry A Charlier, Richard D Olson, Carissa M Thornock, et al.
Frontiers in Cellular and Infection Microbiology|August 1, 2020
Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict EfficacyDerry K Mercer, Marcelo D T Torres, Searle S Duay, et al.
ACS Infectious Diseases|June 10, 2021
Antimicrobial Susceptibility Testing of Antimicrobial Peptides Requires New and Standardized Testing StructuresMarita Meurer, Deborah A O'Neil, Emma Lovie, et al.
Infection and Immunity|March 28, 2018
Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial InfectionDouglas J Fraser-Pitt, Derry K Mercer, Daniel Smith, et al.
Frontiers in Cellular and Infection Microbiology|October 11, 2021
Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in <i>Pseudomonas aeruginosa</i>Douglas J Fraser-Pitt, Stephen K Dolan, David Toledo-Aparicio, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registersLouise K Mercer, Johan Askling, Pauline Raaschou, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2005
A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potentialNeil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Annals of the Rheumatic Diseases|August 21, 2017
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative projectLouise K Mercer, Anne C Regierer, Xavier Mariette, et al.
Journal of Medicinal Chemistry|August 20, 2015
Discovery and Optimization of 4-(8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl)transcyclohexanecarboxylic Acid, an Improved PDE4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)Neil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 10, 2020
Correlating serum alpha-fetoprotein in hepatocellular carcinoma with response to Yttrium-90 transarterial radioembolization with glass microspheres (TheraSphere™)Neal Bhutiani, Stephen J O'Brien, Erin E Priddy, et al.
Molecular Pharmacology|February 12, 2005
Investigations of calsequestrin as a target for anthracyclines: comparison of functional effects of daunorubicin, daunorubicinol, and trifluoperazineHenry A Charlier, Richard D Olson, Carissa M Thornock, et al.
Frontiers in Cellular and Infection Microbiology|August 1, 2020
Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict EfficacyDerry K Mercer, Marcelo D T Torres, Searle S Duay, et al.
ACS Infectious Diseases|June 10, 2021
Antimicrobial Susceptibility Testing of Antimicrobial Peptides Requires New and Standardized Testing StructuresMarita Meurer, Deborah A O'Neil, Emma Lovie, et al.
Infection and Immunity|March 28, 2018
Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial InfectionDouglas J Fraser-Pitt, Derry K Mercer, Daniel Smith, et al.
Frontiers in Cellular and Infection Microbiology|October 11, 2021
Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in <i>Pseudomonas aeruginosa</i>Douglas J Fraser-Pitt, Stephen K Dolan, David Toledo-Aparicio, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registersLouise K Mercer, Johan Askling, Pauline Raaschou, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2005
A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potentialNeil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Annals of the Rheumatic Diseases|August 21, 2017
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative projectLouise K Mercer, Anne C Regierer, Xavier Mariette, et al.
Journal of Medicinal Chemistry|August 20, 2015
Discovery and Optimization of 4-(8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl)transcyclohexanecarboxylic Acid, an Improved PDE4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)Neil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Pageof 10